Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hertz T. Santos-Júnior"'
Autor:
Nelmo V. Menezes, Cynthia S. Barros-Oliveira, Roberto Salvatori, Vinicius C. Gois, Cindi G. Marinho, Carla R. P. Oliveira, Viviane C. Campos, Alécia A. Oliveira-Santos, Hertz T. Santos-Júnior, Elenilde G. Santos, Enaldo V. Melo, Augusto C. N. Faro, Neima V. Oliveira, Hérika M. Gumes-Felix, Gustavo B. Melo, Manuel H. Aguiar-Oliveira
Publikováno v:
International Journal of Retina and Vitreous, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Background The somatotrophic axis, including hypothalamic growth hormone (GH)-releasing hormone (GHRH), pituitary GH and circulating IGF-I, is critical for body size. However, the local production of GH/IGF-I (and IGF-II) and other peptides
Externí odkaz:
https://doaj.org/article/da6e8907cff84f6192bd8d958c80a88c
Autor:
Elenilde G. Santos, Grazielly Bispo da Invenção, Kezia Alves dos Santos, Lysandro Pinto Borges, Saulo E F S Santos, Viviane C. Campos, Igor Leonardo Santos Matos, Manuela A. Melo, Roberto Salvatori, Amélia Ribeiro de Jesus, Nicolas Alessandro Alves Souza, Hertz T Santos-Júnior, Aryanne Araujo Santos, Manuel H. Aguiar-Oliveira, Brenda Morais Oliveira, José Machado Neto, Carla R. P. Oliveira, Enaldo Vieira de Melo, Daniela Raguer Valadão de Souza, Vanderlan O Batista, Pamela Chaves Borges, Alécia A Oliveira-Santos, Cynthia S Barros-Oliveira
Publikováno v:
Endocrine
Purpose Several interactions exist between the GH/IGF axis and the immune system, including effects on innate immunity and humoral and cellular response. Acquired GH deficiency (GHD) has been recently proposed as a risk factor for severity of COVID-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93d29a30cd9017b3e002fd4ed0d97721
https://doi.org/10.1007/s12020-021-02728-8
https://doi.org/10.1007/s12020-021-02728-8
Autor:
Hyder Aragão de Melo, Viviane C. Campos, Elenilde G. Santos, Marco Antônio Prado Nunes, Cynthia S Barros-Oliveira, Nelmo Vasconcelos de Menezes, Roberto Salvatori, Enaldo Vieira de Melo, Manuela A. Melo, Hertz T Santos-Júnior, Cindi G. Marinho, Alécia A Oliveira-Santos, Joselina Luzia Menezes Oliveira, Manuel H. Aguiar-Oliveira, Carla R. P. Oliveira
Publikováno v:
Endocrine. 70:388-395
Cerebrovascular disease (CeVD) is a major cause of death and disability. The role of the GH/IGF-I axis on CeVD risk is controversial. Patients with GH deficiency (GHD) in the setting of hypopituitarism often exhibit CeVD predisposing factors, like lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b213275fa021492c36bf546a59e701f
https://doi.org/10.1007/s12020-020-02415-0
https://doi.org/10.1007/s12020-020-02415-0